Drugs that contain Solifenacin Succinate

1. List of Vesicare Ls drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9918970 ASTELLAS Pharmaceutical composition comprising solifenacin
May, 2031

(8 years from now)

Exclusivity Exclusivity Expiration
New Product (NP) May 26, 2023
Pediatric Exclusivity (PED) Nov 26, 2023

Market Authorisation Date: 26 May, 2020

Treatment: NA

Dosage: SUSPENSION;ORAL

How can I launch a generic of VESICARE LS before it's patent expiration?
More Information on Dosage

VESICARE LS family patents

2

United States

2

Japan

1

South Africa

1

Mexico

1

Australia

1

Slovenia

1

Lithuania

1

Hungary

1

Croatia

1

Brazil

1

Portugal

1

Cyprus

1

Spain

1

Korea, Republic of

1

Poland

1

Taiwan, Province of China

1

RS

1

China

EA

1

EA

1

Canada

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic